R11049 |
PCI34051;PCI-34051 |
PCI-34051 is a potent and selective HDAC8 inhibitor with IC50 of 10 nM, with >
|
R11050 |
SCR7 |
SCR7 is a DNA Ligase IV inhibitor with anticancer activity and is also a CRISPR
|
R11051 |
SB-3CT |
SB-3CT is a potent and competitive matrix metalloproteinase MMP-2 and MMP-9 inhi
|
R11052 |
PF-2545920 |
PF-2545920 is a potent and selective PDE10A inhibitor with IC50&n
|
R11053 |
FIIN-2 |
FIIN-2 is an irreversible inhibitor of FGFR with an IC50 of 3.1, 4.3, 27, and 45
|
R11054 |
AP26113 |
ALK-IN-1 (Brigatinib analog) is a potent and selective active inhibitor of anapl
|
R11055 |
E7080 Mesylate;lenvatinib Mesylate |
Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase in
|
R11056 |
Vandetanib |
N/A
|
R11057 |
Eliglustat hemitartrate (Synonyms: Genz-112638; Eliglustat tartrate) |
Eliglustat tartrate (Genz-112638), a specific inhibitor of glucosylceramide synt
|
R11058 |
Elagolix (NBI-56418) |
Elagolix is a highly potent, selective, orally-active, short-duration, non-pepti
|
R11063 |
Genz-123346 free base |
Genz-123346 (free base) is an inhibitor of GL1 synthase that blocks the conversi
|
R11064 |
Verubecestat (Synonyms: MK-8931) |
Verubecestat (MK-8931) is a beta-secretase 1 (BACE1) inhibitor under investigati
|
R11065 |
Anamorelin intermediate 1 |
N/A
|
R11066 |
Anamorelin intermediate 2 |
N/A
|
R11067 |
Anamorelin intermediate 3 |
N/A
|
R11068 |
Eliglustat intermediate 1 |
N/A
|
R11069 |
Eliglustat intermediate 3 |
Eliglustat is an specific, potent and orally active glucocerebroside synthase in
|
R11070 |
Eliglustat intermediate 4 |
N/A
|
R11071 |
Eliglustat intermediate 5 |
N/A
|
R11072 |
Eliglustat intermediate 6 |
N/A
|
R11073 |
elagolix intermediate 1 |
N/A
|
R11075 |
elagolix intermediate 5 |
N/A
|
R11078 |
elagolix intermediate 10 |
N/A
|
R11079 |
elagolix intermediate 13 |
N/A
|
R11110 |
2-Methyl-1-benzofuran-6-ol |
N/A
|